CA
NZ
UK
AU
IND
US
Merck (NYSE: MRK) announced that the FDA approved its immunotherapy KEYTRUDA alongside WELIREG for kidney cancer patients at high risk of recurrence after surgery. The decision marks a strategic expansion for Merck’s oncology portfolio, positioning the combination as a frontline option in adjuvant kidney …
Codexis (NASDAQ: CDXS) shareholders finalized their annual meeting decisions, endorsing the company’s proposed board of directors without dissent. The vote reaffirms investor alignment with management’s long-term strategy in the biocatalysis sector. The outcome removes near-term governance uncertainty for the biotech firm.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.
Nuvectis Pharma revealed plans to broaden its therapeutic portfolio through a strategic in-licensing deal targeting complement-mediated diseases and oncology. The announcement came during a corporate update call, where leadership emphasized the company’s shift toward high-potential disease areas with limited treatment options. This licensing push …
OpenAI has submitted a confidential filing for a public offering, aiming for a market value near $1 trillion. This development highlights the swift commercialization of artificial intelligence, with rivals such as Anthropic also eyeing public markets. Investors are watching how policy changes could reshape …
CleanSpark (NASDAQ: CLSK) disclosed plans to broaden its activities to include artificial intelligence, describing the new focus as a driver for future growth. The announcement raises questions about how this direction fits with the company’s long‑standing emphasis on microgrid solutions. Stakeholders are evaluating whether …
The 8% gain in Supermicro (NASDAQ: SMCI) shares reflects bullish sentiment toward signals emerging from Nvidia’s (NASDAQ: NVDA) latest AI infrastructure plan. Traders view the uptick as a potential revenue catalyst for server manufacturers geared toward next‑generation AI workloads. This price movement adds to …
Albertsons Companies (NYSE: ACI) prioritizes digital sales and store expansion after a failed merger. The company's digital sales rose 16% in the last quarter, indicating a strong shift towards online shopping. This growth is expected to continue, driven by increasing demand for convenient and …
Nike (NYSE: NKE) has experienced a significant decline in its share price, with losses approaching nearly 65% over recent years. This downturn stands in contrast to broader market performance, raising questions about the company’s ability to regain its footing. Once a leader in athletic …
Target (NYSE: TGT) chair Brian Cornell is confronting unprecedented shareholder discontent as investor support for his leadership reaches a historic low. The decline reflects mounting frustration over the retailer’s recent performance, despite Cornell’s earlier success in expanding the company into a $100 billion enterprise. …
Please wait processing your request...